Dokumendiregister | Terviseamet |
Viit | 13.2-7/24/8003-1 |
Registreeritud | 07.08.2024 |
Sünkroonitud | 08.08.2024 |
Liik | Sissetulev dokument |
Funktsioon | 13.2 Nakkushaiguste labor |
Sari | 13.2-7 NHL kirjavahetus |
Toimik | 13.2-7/2024 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | Rootsi rahvatervise agentuur |
Saabumis/saatmisviis | Rootsi rahvatervise agentuur |
Vastutaja | Janne Pullat (TA, Peadirektori asetäitja (2) vastutusvaldkond, Rahvatervise labor, Nakkushaiguste labor) |
Originaal | Ava uues aknas |
Solna Folkhälsomyndigheten, SE-171 82 Solna. Street address: Nobels väg 18. Östersund Folkhälsomyndigheten, Box 505, 831 26 Östersund.
Street address: Campusvägen 20. +46 10-205 20 00, [email protected], www.folkhalsomyndigheten.se
Recipient
Director General Health Board 10617 Tallinn, Estonia
Administrative Official
Johan Aarum
Date
6 augusti 2024
Page
1 (2)
Information about the planned
refurbishment of the BSL3/4 laboratories at
the Public Health Agency of Sweden
Dear colleagues,
Thank you for your continued confidence in using us as your primary facility for
the analysis of high consequence pathogens. This is an important commitment that
serve to strengthen our joint preparedness against potential biological threats to
human health in our part of Europe.
The BSL3 and 4 laboratories at PHAS was commissioned in 2002 and, although
still well-functioning, now needs refurbishment to secure continual operation at the
highest standard. To allow for this, the BSL3 and 4 facilities at PHAS will be
closed from August 2024 with an expected re-opening date of May 31 2025. We
will duly notify you should there be any changes in the time-plan.
During this period, PHAS will continue to honour our agreement in full with regard
to diagnostic analysis, confirmatory analysis and more in-depth analysis if
required. This means that you can continue to send samples to PHAS. To secure
the proper analysis of all samples, including downstream investigations of samples
that becomes positive, PHAS has contracted other facilities that will complement
our analysis if needed. PHAS will cover all extra costs arising from the use of such
contracted facilities, including shipment- and analysis costs.
Additional information
At the end of 2023 ECDC announced the formation of the initial six European
Reference Laboratories (EURLs). PHAS is happy to inform you that we will
coordinate the EURL for Emerging, rodent-borne and zoonotic viral pathogens
(EU4H-2023-DGA-MS-IBA-02-03) and participate in the EURL for High-risk,
emerging and zoonotic bacterial pathogens (EU4H-2023-DGA-MS-IBA-02-04),
the latter coordinated by our partner Robert Koch Institute in Germany. Part of
your agreed services with us will be covered by the newly formed EURLs, planned
Page 2 (2)
Solna Folkhälsomyndigheten, SE-171 82 Solna. Street address: Nobels väg 18. Östersund Folkhälsomyndigheten, Box 505, 831 26 Östersund.
Street address: Campusvägen 20. +46 10-205 20 00, [email protected], www.folkhalsomyndigheten.se
to be operational in the first quarter of 2025. This includes, for example,
diagnostics of agent X. However, we would like to stress that in our current
bilateral agreements we offer a considerably higher and more timely preparedness
than what will be provided through the EURLs. We therefor hope that you see our
continued cooperation around this as important, not the least in view of our joint
Nordic/Scandinavian preparedness against biological threats. In this regard, we will
be in contact with you again closer to the re-opening of our BSL3 and 4 facilities to
initiate discussions around renewal of our current agreements and possibilities to
strengthen our cooperation further.
Meanwhile, please do not hesitate to contact us should you have any questions or
thought concerning the above.
Yours sincerely,
Johan Aarum
Head of Unit for Diagnostic Preparedness of Notifiable and High Consequence
Pathogens
Public Health Agency of Sweden
+4610-205 21 77